By
The U.S. Food and Drug Administration recalled thousands of bottles of antidepressants due to the medicines containing high levels of a cancer-causing chemical.
Now, the FDA is assigning the second-highest risk level to the recall of Duloxetine Delayed-Release Capsules produced by Towa Pharmaceutical Europe
Site Title 